Collection of Anonymized Data for Improvement of Domestic Patient Monitor System
Sponsor
Seoul National University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04671199
Collaborator
(none)
100
1
12.2
8.2
Study Details
Study Description
Brief Summary
Collection of anonymized data for improvement of domestic patient monitor system comparison of commercial patient monitor
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
the data from the patient will be collected as the baseline data for improvement of the domestic patient monitor system
Study Design
Study Type:
Observational
Anticipated Enrollment
:
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Data Collection for Improvement of Domestic Patient Monitor
Anticipated Study Start Date
:
Dec 25, 2020
Anticipated Primary Completion Date
:
Dec 24, 2021
Anticipated Study Completion Date
:
Dec 31, 2021
Outcome Measures
Primary Outcome Measures
- anoymized data collection [during surgery]
agreement of ECG data from the 2 different patient monitor
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- surgical patients
Exclusion Criteria:
- problem to monitor
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | SNUH | Seoul | Jongnogu | Korea, Republic of | 03080 |
Sponsors and Collaborators
- Seoul National University Hospital
Investigators
- Principal Investigator: Hee-Soo Kim, MD, Seoul National University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hee-Soo Kim,
professor,
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT04671199
Other Study ID Numbers:
- 20111521176
First Posted:
Dec 17, 2020
Last Update Posted:
Dec 17, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No